Fibrinolysis in Retinal Vascular Occlusions
This is a brief interim report on the use of streptokinase as a fibrinolytic agent in retinal vascular occlusions. It is based on the work of the team of the Royal Eye Medical Ophthalmology Unit.
In recent years, numerous reports have been published of the successful use of streptokinase in vascular thrombosis at different sites throughout the body. Only a few studiesand these mainly of isolated caseshave emerged of the results of this therapy in vascular occlusions in the retina.
Mode ofAction of Streptokinase
Plasminogen is an inactive globulin present in normal blood. Under certain conditions, it is converted to plasmin, an active agent which dissolves the fibrin in thrombi. This change from plasminogen to plasmin can be effected by the enzyme streptokinase. In our series of cases we used streptokinase on the assumption that thrombosis played some partthough not necessarily a major partin the production of the vascular block.
Administration: An intravenous drip containing normal saline was set up. Into this was injected hydrocortisone hemisuccinate 100 mg. Streptokinase was then given as a continuous intravenous infusion over many hours; this in turn was followed by a course of anticoagulants (heparin and phenindione).
Arterial occlusions: Of the 12 patients treated, 6 had arterial occlusions.
In 3 of these cases, occlusion was considered to be part of an inflammatory process. Large doses of systemic corticosteroids were given and on this account the part played by fibrinolysis in the evolution of the clinical picture cannot be accu-31 rately assessed. However, in these cases there were no significant ocular or systemic complications of streptokinase therapy. Table 1 sets out some of the details of the remaining 3 arterial cases (Case 3 was treated twice). From 4 h 40 min to 8 h 25 min elapsed before treatment was started; by this time the visual acuity in each case was about 'hand movements' and no pulsation on pressure could be elicited from the central retinal artery. Intravenous streptokinase therapy was commenced. Time intervals before arterial pulsation returned are shown in the third column and the ultimate visual acuity in the fourth. In Cases 1 and 3 the peripheral field suffered far less than the central area; but the optic discs became pale and the retinal arteries remained rather narrow.
Case 1 Woman, aged 47 Angiography two months after treatment revealed a normal internal carotid artery and the choroid coat was seen clearly on X-ray. Case 2 Man, aged 63. Hypertensive About four hours after streptokinase was started, he began to develop neurological signs and died within forty-eight hours from a cerebral haemorrhage. Case 3 Man, aged 52 Angiography showed an almost complete occlusion of the internal carotid artery. His retinal artery became occluded a second time. Subsequent internal carotid thromboendarterectomy was unsuccessful due to the extension of the thrombus up to the carotid siphon.
In assessing the role played by any form of therapy in these cases the possibility of spontaneous recovery of vision must be considered; indeed Cases 2 and 3 had earlier experienced temporary visual loss with full recovery. However, if we exclude the retreatment of Case 3, which was evidently ineffective, the figures in the third column would suggest that the rapid restoration of arterial pulsation was due to streptokinase therapy.
Venous occlusions: Six patients with retinal venous occlusions were treated; of these 5 were central and 1 branch. Table 2 shows the time that elapsed in each case before treatment was begun and the visual results. In no case was there any improvement in the fundus appearances that could be attributed to therapy.
In only 2 patients (Cases 8 and 9) was there an improvement in the visual acuity. But Case 8 was judged to be an incomplete occlusion and Case 9 was a superior nasal vein occlusion (which persisted); so that this improvement might have been expected in the natural course of events.
On the other hand, in Cases 5 and 6 further hemorrhages occurred in the eye after the commencement of therapy. In Case 5 a preretinal hemorrhage was seen five hours after starting streptokinase. In Case 6 retinal hemorrhages increased within twenty-four hours and a hyphoema occurred on the eleventh day. In both cases new vessels formed early on the iris and in the chamber angle, glaucoma supervened, and the ultimate visual acuity was no perception of light.
Conclusions
There was no clear indication that streptokinase therapy benefited any of our 6 patients with venous occlusions. In 2 cases it appeared to make the condition worse. It has, therefore, been decided to discontinue its use. However, streptokinase appeared to be of value in restoring pulsation in blocked central retinal arteries. We have decided to study further the effect of this therapy on recent arterial occlusions. The Ocular Effects of Autonomic Surgery
As I am an otolaryngologist, dependent on the active help of my ophthalmic colleagues, my remarks will be confined to changes in lacrimal secretion and intraocular tension produced by resections of the petrosal parasympathetic pathways.
The Petrosal Pathways The secretomotor fibres both to lacrimal gland and nasal mucosa arise in the superior salivatory nucleus, emerge from the pons, and run with the facial nerve to the geniculate ganglion. Thence they continue forwards extradurally over the petrous, towards foramen lacerum, uniting with sympathetic fibres from internal carotid plexus. These conjoined fibres form the vidian nerve which runs forward through the pterygoid canal to join the sphenopalatine ganglion in the pterygopalatine fossa. Here, the parasympathetic fibres relay before distribution. The lacrimal fibres join the maxillary nerve and enter its zygomatic branch, reaching lacrimal gland through the zygomaticotemporal branch or fine connexions to the lacrimal nerve. Elsewhere (Golding-Wood 1961, 1962a) I have contended that many cases of paroxysmal sneezing and rhinorrhcea, often associated with lacrimation, hitherto believed allergic, are in fact largely psychosomatic in character. The symptoms are due to the cholinergic effects of localized parasympathetic over-activity. In severe and intractable cases this hypothesis has been tested by surgical section of the final effector pathways. Initially, I used greater superficial petrosal neurectomy in the middle cranial fossa, but later devised a transantral exposure for vidian neurectomy. This gives equivalent results with much less disturbance and is free of significant risk. This preganglionic sec-
